| Literature DB >> 22194318 |
Rachel Savage1, Anna Chu, Laura C Rosella, Natasha S Crowcroft, Monali Varia, Michelle E Policarpio, Norman G Vinson, Anne-Luise Winter, Karen Hay, Richard F Davies, Ian Gemmill, Don Willison, Ian Johnson.
Abstract
BACKGROUND: Despite the growing popularity of syndromic surveillance, little is known about if or how these systems are accepted, utilized and valued by end users. This study seeks to describe the use of syndromic surveillance systems in Ontario and users' perceptions of the value of these systems within the context of other surveillance systems.Entities:
Mesh:
Year: 2011 PMID: 22194318 PMCID: PMC7313939 DOI: 10.1093/pubmed/fdr088
Source DB: PubMed Journal: J Public Health (Oxf) ISSN: 1741-3842 Impact factor: 2.341
Description of sources of surveillance information included in the survey
|
|
|
|
|---|---|---|
| Public health laboratory tests | No | Confirmatory reports of cases with infectious diseases from public health laboratory testing |
| iPHIS | No | Ontario's reportable disease database containing local and provincial information collected and entered by PHU personnel from active follow-up of individuals with a laboratory-confirmed reportable infectious disease |
| School absenteeism | Yes | All cause or illness-related school absenteeism rates or counts |
| Community sentinel ILI consults | Yes | Counts or rates of patients seeking care from community sentinel practitioners (physicians and nurse practitioners) with symptoms of ILI as a proportion of all patients seeking medical care |
| ED visits | Yes | Data based on patient visits to EDs such as total patients seeking care and counts by chief complaints categorized by syndrome |
| Telehealth | Yes | All cause or symptom-related call data from a free nurse consultation telephone service provided by the MOHLTC |
| Hospital/clinic screening data (includes ED screening) | Yes | Screening data (usually for ILI or febrile respiratory illness) from patients seeking care in hospital EDs or clinics regardless of chief complaint |
| Workplace absenteeism | Yes | All cause or illness-related absenteeism rates or counts in a workplace |
| Outpatient data | Yes | Information from health care providers in an outpatient setting |
| Pharmacy sales | Yes | Data from over-the-counter or prescription drug sales |
| Emergency medical service/911 call data | Yes | Data collected by emergency medical services personnel or from calls to 911 |
Percentage of organizations receiving notification of suspected outbreaks or unusual events by source of surveillance information, Ontario, 2010
|
|
|
|
|---|---|---|
| Public health laboratory tests | 37 (100) | 37 |
| iPHIS | 37 (97) | 38 |
| School absenteeism | 37 (97) | 38 |
| Community sentinel ILI consults | 35 (92) | 38 |
| ED visits | 25 (66) | 38 |
| Telehealth | 24 (63) | 38 |
| Hospital/clinic screening data | 14 (38) | 37 |
| Workplace absenteeism | 9 (24) | 37 |
| Outpatient data | 8 (22) | 37 |
| Pharmacy sales | 6 (16) | 37 |
| Emergency medical service/911 call data | 2 (5) | 37 |
Perceptions of data source reliability, timeliness and accuracy as ‘very acceptable’ by organizations who receive notification from that source (ordered by most acceptable reliability), Ontario, 2010
|
|
| ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||
|
|
|
|
|
|
| ||
| Public health laboratory tests | 92 | 80, 98 | 51 | 35, 67 | 89 | 76, 96 | 37 |
| iPHIS | 84 | 69, 93 | 43 | 28, 59 | 62 | 46, 77 | 37 |
| Hospital/clinic screening data | 50 | 25, 75 | 43 | 20, 69 | 43 | 20, 69 | 14 |
| ED visits | 48 | 28, 68 | 35 | 18, 56 | 48 | 28, 68 | 23b |
| Community sentinel ILI consults | 39 | 24, 57 | 18 | 8, 34 | 25 | 12, 42 | 33c |
| School absenteeism | 22 | 11, 38 | 42 | 27, 58 | 22 | 11, 38 | 36d |
| Telehealth | 29 | 12, 50 | 23 | 9, 43 | 27 | 12, 48 | 22e |
aResponses for workplace absenteeism, outpatient data, pharmacy sales and emergency medical service/911 data are not displayed due to the low number of organizations using these data sources.
bTwo responses missing.
cTwo responses missing for reliability and timeliness, three responses missing for accuracy.
dOne response missing.
eTwo responses missing for timeliness and accuracy, three responses missing for reliability.
Fig. 1Data sources used by organizations to monitor the epidemiology of 2009 pandemic H1N1 and inform decision-making, Ontario. *Other includes EMS/paramedic activities, hospital admission, intensive care unit and ventilator use data, immunization visits, influenza assessment centre visits and provincial surveillance bulletins and teleconferences.
Level of usefulness of data sources in monitoring 2009 pandemic H1N1 epidemiology and informing decision-making and actions for organizations who reported use of these sources during the pandemic (ordered by most ‘essential’ in monitoring the epidemiology), Ontario
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
|
|
|
|
| |||
| Public health laboratory tests for influenza A | 71 | 55, 84 | 38 | 76 | 60, 87 | 37 |
| iPHIS | 56 | 39, 71 | 36 | 63 | 45, 79 | 30 |
| ED screening | 52 | 34, 69 | 29 | 70 | 51, 85 | 27 |
| ED visits | 52 | 33, 71 | 25 | 68 | 48, 84 | 25 |
| School absenteeism | 41 | 26, 57 | 37 | 41 | 26, 58 | 34 |
| Organization telephone information line | 26 | 11, 47 | 23 | 36 | 19, 58 | 22 |
| Community sentinel ILI consults | 23 | 10, 40 | 31 | 29 | 12, 50 | 21 |
| Calls from physicians or hospitals | 21 | 8, 40 | 24 | 43 | 23, 64 | 21 |
| Telehealth | 0 | 0, 14 | 20 | 0 | 0, 39 | 6 |
aResponses for workplace absenteeism, outpatient data, pharmacy sales and emergency medical service/911 data are not displayed due to the low number of organizations using these data sources.
b n represents the number of organizations who reported using the data source for monitoring H1N1 epidemiology and/or informing decision-making.